Outcomes of Molecular Characteristics in Chinese BAP1-Mutant Non-Small Cell Lung Cancer Patients

被引：0
|
作者：
Ke, H. [1 ]
Xu, C. [2 ]
Wang, W. [3 ]
Zhang, Q. [4 ]
Zhuang, W. [2 ]
Zhu, Y. [5 ]
Huang, Y. [2 ]
Chen, G. [4 ]
Fang, M. [3 ]
Lv, T. [6 ]
Song, Y. [6 ]
机构：
[1] Nantong Univ, Affiliated Hosp, Nantong, Peoples R China
[2] Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[3] Zhejiang Canc Hosp, Chemotherapy, Hangzhou, Zhejiang, Peoples R China
[4] Fujian Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China
[5] Zhejiang Rongjun Hosp, Thorac Dis Ctr, Jiaxing, Peoples R China
[6] Jinling Hosp, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
non-small-cell lung cancer; BAP1; mutation; prognosis;
D O I：
10.1016/j.jtho.2019.08.2098
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.03-17
引用
收藏
页码：S960 / S960
页数：1
相关论文
共 50 条
  • [21] PDGFRA Defines a Unique Molecular Subtypes of Chinese Non-Small Cell Lung Cancer Patients
    Xu, C.
    Wang, W.
    Zhang, Q.
    Zhuang, W.
    Zhu, Y.
    Chen, Y.
    Fang, M.
    Chen, G.
    Lv, T.
    Song, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S720 - S720
  • [22] Characteristics and outcomes of patients with unresected early-stage non-small cell lung cancer
    Kyasa, MJ
    Jazieh, AR
    [J]. SOUTHERN MEDICAL JOURNAL, 2002, 95 (10) : 1149 - 1152
  • [23] Clinical and molecular characteristics of non-small cell lung cancer in patients harboring CTNNB1 mutations
    Gogl, L.
    Scheffler, M.
    Ihle, M.
    Michels, S. Y. F.
    Fischer, R.
    Serke, M. H.
    Gerigk, U.
    Woempner, C.
    Krueger, S.
    Kaminsky, B.
    Schulte, W.
    Hoeffken, G.
    Merkelbach-Bruse, S.
    Buettner, R.
    Wolf, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S647 - S647
  • [24] Clinical and molecular characteristics of non-small cell lung cancer in patients harboring CTNNB1 mutations
    Gogl, L.
    Scheffier, M.
    Ihle, M.
    Michels, S.
    Fischer, R.
    Serke, M.
    Gerigk, U.
    Woempner, C.
    Krueger, S.
    Kaminsky, B.
    Schulte, W.
    Hoeffken, G.
    Merkelbach-Bruse, S.
    Buettner, R.
    Wolf, J.
    [J]. Oncology Research and Treatment, 2015, 38 : 269 - 269
  • [25] BAP1 is a good prognostic factor in advanced non-small cell lung cancer
    Fan, Li-hong
    Tang, Li-na
    Yue, Lu
    Yang, Yi
    Gao, Zhong-li
    Shen, Zan
    [J]. CLINICAL AND INVESTIGATIVE MEDICINE, 2012, 35 (04): : L182 - L189
  • [26] Impact of race on outcomes of patients with non-small cell lung cancer
    Bryant, Ayesha S.
    Cerfolio, Robert James
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (07) : 711 - 715
  • [27] VIETNAMESE NON-SMALL CELL LUNG CANCER PATIENTS IN CALIFORNIA: MOLECULAR PROFILES AND CLINICAL CHARACTERISTICS
    Nguyen, Kim-Son H.
    Das, Millie
    Ramchandran, Kavitha
    Shrager, Joseph
    Merritt, Robert E.
    Hoang, Chuong
    Burt, Bryan
    Tisch, Alison
    Pagtama, Judy
    Zehnder, James
    Berry, Gerald
    Wakelee, Heather A.
    Anh-Hoa Nguyen
    Neal, Joel W.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S208 - S209
  • [28] Molecular characteristics of non-small cell lung cancer (NSCLC) patients sensitive to gefitinib.
    Pao, W
    Zakowski, M
    Cordon-Cardo, C
    Ben-Porat, L
    Kris, MG
    Miller, VA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 623S - 623S
  • [29] Molecular mechanisms driving oncogenesis in KRAS mutant non-small cell lung cancer
    Holderfield, Matthew
    McCormick, Frank
    Nagel, Tobi
    [J]. CANCER RESEARCH, 2010, 70
  • [30] Real-World Characteristics and Outcomes of ERBB2-Mutant Non-small Cell Lung Cancer in Latin America Patients
    Saldanha, E.
    De Lima, V. C. C.
    Corassa, M.
    Arrieta, O.
    Fares, A.
    Santana, L. Gil
    Soler, J. A.
    Chamorro, D.
    Rodriguez, J.
    Freitas, H.
    Cardona, A. F.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S661 - S661
12345